PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).
Molecular Weight:
502.6
Purity:
>98% (HPLC)
CAS Number:
[1370448-25-1]
Formula:
C28H30N4O5
* VAT and and shipping costs not included. Errors and price changes excepted